The abortion pill mifepristone will remain available in the United States for now but with significant restrictions, including a requirement for in-person doctor visits to obtain the drug, a federal appeals court ruled late on Wednesday.The New Orleans-based Fifth US Circuit Court of Appeals put on hold part of last Friday’s order by US District Judge Matthew Kacsmaryk in Amarillo, Texas, that had suspended the US Food and Drug Administration (FDA) approval for the drug while he hears a lawsuit by anti-abortion groups seeking to ban it.The Biden administration and the maker of brand-name mifepristone, Danco Laboratories, had quickly asked for an emergency stay of that order.
Load More
Load More